Company / Current Liabilities
Tango Therapeutics, Inc. Current Liabilities History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$21.7M
FY2025
5-year range
$21.7M / $55.5M
FY2021-FY2025
Trend
-43.2%
vs FY2024
Sector context
#187 of 213
Health Care
What the data says
Tango Therapeutics, Inc.'s current liabilities of $22M is lower than 88% of companies in the Health Care sector (FY2025). Current Liabilities has declined for 3 consecutive years, from $56M in FY2022 to $22M in FY2025.
Based on SEC 10-K filings.
$22M in FY2025 with a 5-year CAGR of -11.9%.
Improved from $46M to $22M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -26.9%
- 5-Year CAGR
- -11.9%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 213This company $21.7M Sector average $1.6B
▼
-98.6% below sector average
Key checks
Key Insights
- Tango Therapeutics, Inc.'s current liabilities has declined for 3 consecutive years.
- 5-year CAGR of -11.9%, indicating a declining trend.
- In FY2025, current liabilities decreased 43.2% year-over-year.
- Ranks #187 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.7M | -43.2% |
| FY2024 | $38.2M | -16.9% |
| FY2023 | $45.9M | -17.3% |
| FY2022 | $55.5M | +36.5% |
| FY2021 | $40.7M | -0.6% |
| FY2020 | $40.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026